PL1948666T3 - Inhibitory integrazy HIV - Google Patents

Inhibitory integrazy HIV

Info

Publication number
PL1948666T3
PL1948666T3 PL06837651T PL06837651T PL1948666T3 PL 1948666 T3 PL1948666 T3 PL 1948666T3 PL 06837651 T PL06837651 T PL 06837651T PL 06837651 T PL06837651 T PL 06837651T PL 1948666 T3 PL1948666 T3 PL 1948666T3
Authority
PL
Poland
Prior art keywords
hiv integrase
integrase inhibitors
inhibitors
hiv
integrase
Prior art date
Application number
PL06837651T
Other languages
English (en)
Inventor
B Narasimhulu Naidu
Yasutsugu Ueda
John D Matiskella
Michael A Walker
Jacques Banville
Francis Beaulieu
Carl Ouellet
Serge Plamondon
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PL1948666T3 publication Critical patent/PL1948666T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL06837651T 2005-11-17 2006-11-15 Inhibitory integrazy HIV PL1948666T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73778105P 2005-11-17 2005-11-17
US11/590,637 US8039458B2 (en) 2005-11-17 2006-10-31 HIV integrase inhibitors
PCT/US2006/044320 WO2007061714A1 (en) 2005-11-17 2006-11-15 Hiv integrase inhibitors
EP06837651A EP1948666B1 (en) 2005-11-17 2006-11-15 Hiv integrase inhibitors

Publications (1)

Publication Number Publication Date
PL1948666T3 true PL1948666T3 (pl) 2010-08-31

Family

ID=38041727

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06837651T PL1948666T3 (pl) 2005-11-17 2006-11-15 Inhibitory integrazy HIV

Country Status (20)

Country Link
US (1) US8039458B2 (pl)
EP (1) EP1948666B1 (pl)
JP (1) JP2009515981A (pl)
KR (1) KR20080069254A (pl)
CN (1) CN101360752B (pl)
AR (1) AR057896A1 (pl)
AT (1) ATE461202T1 (pl)
AU (1) AU2006316582B2 (pl)
CY (1) CY1110665T1 (pl)
DE (1) DE602006013025D1 (pl)
DK (1) DK1948666T3 (pl)
ES (1) ES2341132T3 (pl)
HR (1) HRP20100247T1 (pl)
NO (1) NO20081935L (pl)
PE (1) PE20071080A1 (pl)
PL (1) PL1948666T3 (pl)
PT (1) PT1948666E (pl)
SI (1) SI1948666T1 (pl)
TW (1) TW200738728A (pl)
WO (1) WO2007061714A1 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763630B2 (en) * 2007-06-06 2010-07-27 Bristol-Myers Squibb Company HIV integrase inhibitors
ES2530064T3 (es) * 2008-02-07 2015-02-26 Bayer Cropscience Ag Arilpirrolinas insecticidas
US8129398B2 (en) * 2008-03-19 2012-03-06 Bristol-Myers Squibb Company HIV integrase inhibitors
WO2010042391A2 (en) * 2008-10-06 2010-04-15 Merck Sharp & Dohme Corp. Hiv integrase inhibitors
US8143244B2 (en) 2009-02-26 2012-03-27 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
ES2536278T3 (es) 2009-05-19 2015-05-22 Bayer Intellectual Property Gmbh Arilpirrolinas insecticidas
ES2446720T3 (es) * 2009-10-13 2014-03-10 Elanco Animal Health Ireland Limited Inhibidores de la integrasa macrocíclica
US8383639B2 (en) * 2009-10-15 2013-02-26 Bristol-Myers Squibb Company HIV integrase inhibitors
US8283366B2 (en) 2010-01-22 2012-10-09 Ambrilia Biopharma, Inc. Derivatives of pyridoxine for inhibiting HIV integrase
JP5935154B2 (ja) 2011-03-14 2016-06-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｇｐｒ１１９モジュレーターとしてのｎ−シクロプロピル−ｎ−ピペリジニルベンズアミド
JP6094578B2 (ja) 2011-06-09 2017-03-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 代謝性障害の治療のためのｇｐｒ１１９モジュレーターとしての置換ピペリジン
ES3018133T3 (en) 2011-11-30 2025-05-14 Univ Emory Jak inhibitors for use in the prevention or treatment of a viral disease caused by a coronaviridae
JP2015523404A (ja) 2012-08-02 2015-08-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｎ−シクロプロピル−ｎ−ピペリジニル−アミド、これらを含有する医薬組成物およびその使用
EP2931730B1 (en) 2012-12-17 2019-08-07 Merck Sharp & Dohme Corp. 4-pyridinonetriazine derivatives as hiv integrase inhibitors
US9493479B2 (en) 2013-04-16 2016-11-15 Merck Sharp & Dohme Corp. Substituted pyrido[1,2-a]pyrazines as HIV integrase inhibitors
MX2015014688A (es) 2013-04-22 2016-02-19 Abbvie Inc Tiazoles y usos de los mismos.
RS56701B1 (sr) 2013-05-17 2018-03-30 Merck Sharp & Dohme Fuzionisana triciklična heterociklična jedinjenja kao inhibitori hiv integraze
EP3008044B1 (en) 2013-06-13 2018-11-21 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
UA117499C2 (uk) 2013-09-27 2018-08-10 Мерк Шарп Енд Доум Корп. Заміщені похідні хінолізину, які можна використовувати як інгібітори інтегрази віл
BR112017014980B1 (pt) * 2015-01-16 2021-11-16 Bayer Cropscience Aktiengesellschaft Método para preparação de hidrocloreto de 4-cianopiperidina
WO2016187788A1 (en) 2015-05-25 2016-12-01 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds useful for treating hiv infection
US10548910B2 (en) 2015-11-17 2020-02-04 Merck Sharp & Dohme Corp. Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors
US10544155B2 (en) 2015-12-15 2020-01-28 Merck Sharp & Dohme Corp. Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors
WO2017113288A1 (en) 2015-12-31 2017-07-06 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
WO2018010163A1 (zh) * 2016-07-15 2018-01-18 泸州东方农化有限公司 一种1,2,4-三唑-3-硫酮化合物的合成方法及其中间体
JOP20190130A1 (ar) 2016-12-02 2019-06-02 Merck Sharp & Dohme مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv)
CA3042314A1 (en) 2016-12-02 2018-06-07 Merck Sharp & Dohme Corp. Tricyclic heterocycle compounds useful as hiv integrase inhibitors
EP3573984A4 (en) 2017-01-26 2020-07-29 Merck Sharp & Dohme Corp. USEFUL SUBSTITUTE QUINOLIZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS
WO2020221294A1 (zh) * 2019-04-30 2020-11-05 上海拓界生物医药科技有限公司 桥环-3,4-二氢-吡啶并[1,2-a]吡嗪-1,8-二酮化合物及其药物用途
CN114426540B (zh) * 2020-10-29 2024-04-26 上海拓界生物医药科技有限公司 吡啶并[1,2-a]吡嗪-1,8-二酮类前药衍生物、其制备方法及其应用
CN113372335B (zh) * 2021-07-05 2023-02-24 山东大学 一种含有1,2,4-三唑硫醚的苯丙氨酸衍生物及其制备方法与应用
WO2026070814A1 (ja) * 2024-09-30 2026-04-02 大日本印刷株式会社 重合性液晶化合物及びその製造方法、重合性組成物、重合体、位相差フィルム及びその製造方法、転写用積層体、光学部材及びその製造方法、並びに表示装置
CN121873064A (zh) * 2024-10-17 2026-04-17 博远医药(苏州)有限公司 杂环类衍生物及其药物组合物和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ540729A (en) * 2002-12-27 2008-03-28 Angeletti P Ist Richerche Bio Tetrahydro-4H-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors
AR046938A1 (es) 2003-12-12 2006-01-04 Merck & Co Inc Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares
TW200526635A (en) 2003-12-22 2005-08-16 Shionogi & Co Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
CA2600832C (en) * 2005-03-31 2011-12-13 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Hiv integrase inhibitors
WO2006121831A2 (en) 2005-05-10 2006-11-16 Merck & Co., Inc. Hiv integrase inhibitors

Also Published As

Publication number Publication date
AU2006316582A1 (en) 2007-05-31
WO2007061714A1 (en) 2007-05-31
PE20071080A1 (es) 2007-11-19
NO20081935L (no) 2008-06-24
KR20080069254A (ko) 2008-07-25
TW200738728A (en) 2007-10-16
PT1948666E (pt) 2010-05-17
JP2009515981A (ja) 2009-04-16
EP1948666A1 (en) 2008-07-30
AR057896A1 (es) 2007-12-26
CN101360752B (zh) 2012-09-05
ATE461202T1 (de) 2010-04-15
HRP20100247T1 (hr) 2010-06-30
AU2006316582B2 (en) 2012-01-19
EP1948666B1 (en) 2010-03-17
ES2341132T3 (es) 2010-06-15
CN101360752A (zh) 2009-02-04
US8039458B2 (en) 2011-10-18
US20070111984A1 (en) 2007-05-17
DE602006013025D1 (de) 2010-04-29
CY1110665T1 (el) 2015-06-10
DK1948666T3 (da) 2010-05-25
SI1948666T1 (sl) 2010-06-30

Similar Documents

Publication Publication Date Title
PL1948666T3 (pl) Inhibitory integrazy HIV
EP1756069A4 (en) HIV INTEGRASE INHIBITORS
IL177189A0 (en) Hiv integrase inhibitors
IL177858A0 (en) Hiv integrase inhibitors
TWI366567B (en) Bicyclic heterocycles as hiv integrase inhibitors
IL179161A0 (en) Hiv integrase inhibitors: cyclic pyrimidinone compounds
IL192208A0 (en) Methods for improving the pharmacokinetics of hiv integrase inhibitors
IL188615A0 (en) Hiv reverse transcriptase inhibitors
EP1753767A4 (en) BICYCLIC HETEROCYCLES AS HIV INTEGRASE INHIBITORS
EP1749008A4 (en) BICYCLIC HETEROCYCLES AS HIV INTEGRASE INHIBITORS
ZA201102620B (en) Hiv integrase inhibitors
IL183850A0 (en) Hiv protease inhibitors
AP2005003451A0 (en) HIV integrase inhibitors.
EP1910363A4 (en) INHIBITORS OF HIV INTEGRASE
ZA200709605B (en) HIV vaccine
EP1855672A4 (en) HIV PROTEASE INHIBITORS
IL189939A0 (en) Inhibitors of the hiv integrase enzyme
EP1910356A4 (en) HIV integrase
ZA200706305B (en) HIV protease inhibitors
ZA200800185B (en) Hiv reverse transcriptase inhibitors
EP1910355A4 (en) HIV integrase
EP1909578A4 (en) INHIBITORS OF HIV INTEGRASE
ZA200804099B (en) Multiclade HIV vaccines
ZA200606956B (en) HIV integrase inhibitors
ZA200806222B (en) Methods for improving the pharmacokinetics of HIV integrase inhibitors